DRKS00041144Active, not recruitingNot Applicable
A prospective, randomized, controlled, multicenter study to evaluate the efficacy and safety of the designated Digital Application "OsteoCoach" for fall prevention, fracture prevention and enhanced mobility in older adults with osteoporosis
Osteoconnect GmbH0 sites182 target enrollmentStarted: March 9, 2026Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 182
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- 65 Years to — (—)
- Sex
- All
Inclusion Criteria
- •Medically documented osteoporosis (ICD-10-GM M80.– or M81.–); access to a smartphone or tablet with an internet connection; sufficient digital literacy; sufficient spoken and written German language skills; written informed consent.
Exclusion Criteria
- •Severe cognitive impairment preventing safe use; unstable cardiovascular disease; medical restriction against physical exertion; severe neurological dysfunction; other circumstances preventing use of the intervention.
Investigators
Similar Trials
Recruiting
Not Applicable
A Clinical Study to Evaluate the Efficacy and Safety of Pulmonary Rehabilitation Software EB-S100 in Patients with Chronic Obstructive Pulmonary DiseaseDiseases of the respiratory systemKCT0012275Emocog Co., Ltd.64
Recruiting
Not Applicable
Phase III study of KD2-396Prevention of pertussis, diphtheria, tetanus, poliomyelitis(polio), Hib infection, and hepatitis BjRCT2031250804540
Active, not recruiting
Phase 3
A clinical study to evaluate the immunogenicity, safety and lot-to-lot
consistency of Measles, Mumps and Rubella vaccine in healthy infants aged 9-12 monthsCTRI/2026/07/113522Zydus Lifesciences Limited3,500
Active, not recruiting
Not Applicable
Artificial Intelligence-Based Prediction of Invasion Depth in Superficial Esophageal CancerNeoplasmsKCT0012269Samsung Medical Center110
Recruiting
Not Applicable
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast CancerPIK3CA-mutated HER2-positive locally advanced or metastatic breast cancerjRCT2031250577230